Polypodium leucotomos targets multiple aspects of oral carcinogenesis and it is a potential antitumor phytotherapy against tongue cancer growth

Autor(es):Mostrar menos -

Lacerda, Pammela A. ; Oenning, Luan C. ; Bellato, Guilherme Cuoghi ; Lopes-Santos, Lucilene ; Antunes, Natalicia de Jesus ; Mariz, Bruno Augusto Linhares Almeida ; Teixeira, Gabriela ; Vasconcelos, Rafael ; Simoes, Gustavo Ferreira ; de Souza, Ivani Aparecida ; Pinto, Clovis Antonio Lopes ; Salo, Tuula ; Coletta, Ricardo D. ; Augusto, Taize M. ; de Oliveira, Carine Ervolino ; Cervigne, Nilva K.

• Tipo de documento: Artigo Científico
• Fonte: FRONTIERS IN PHARMACOLOGY; v. 13, p. 18-pg., 2023-01-05.

Resumo

Introduction: Oral cancer refers to malignant tumors, of which 90% are squamous cell carcinomas (OSCCs). These malignancies exhibit rapid progression, poor prognosis, and often mutilating therapeutical approaches. The determination of a prophylactic and/or therapeutic antitumor role of the polyphenolic extract Polypodium leucotomos(PL) would be relevant in developing new tools for prevention and treatment.Methods: We aimed to determine the antitumor effect of PL by treating OSCC cell lines with PL metabolites and evaluating its action during OSCC progression in vivo.Results: PL treatment successfully impaired cell cycling and proliferation, migration, and invasion, enhanced apoptosis, and modulated macrophage polarization associated with the tumoral immune-inflammatory response of tongue cancer cell lines (TSCC). PL treatment significantly decreased the expression of MMP1 (p < 0.01) and MMP2 (p < 0.001), and increased the expression of TIMP1 (p < 0.001) and TIMP2 (p < 0.0001) in these cells. The mesenchymal-epithelial transition phenotype was promoted in cells treated with PL, through upregulation of E-CAD (p < 0.001) and reduction of N-CAD (p < 0.05). PL restrained OSCC progression in vivo by inhibiting tumor volume growth and decreasing the number of severe dysplasia lesions and squamous cell carcinomas. Ki-67 was significantly higher expressed in tongue tissues of animals not treated with PL(p < 0.05), and a notable reduction in Bcl2 (p < 0.05) and Pcna (p < 0.05) cell proliferation-associated genes was found in dysplastic lesions and TSCCs of PL-treated mice. Finally, N-cad(Cdh2), Vim, and Twist were significantly reduced in tongue tissues treated with PL.Conclusion: PL significantly decreased OSCC carcinogenic processes in vitro and inhibited tumor progression in vivo. PL also appears to contribute to the modulation of immune-inflammatory oral tumor-associated responses. Taken together, these results suggest that PL plays an important antitumor role in processes associated with oral carcinogenesis and may be a potential phytotherapeutic target for the prevention and/or adjuvant treatment of TSCCs (AU)

• Processo FAPESP: 19/09693-5 - "estudo da atividade do receptor de andrógeno sobre a modulação da heparanase no câncer de próstata"
• Beneficiário: Taize Machado Augusto
• Modalidade de apoio: Auxílio à Pesquisa - Regular
• Processo FAPESP: 15/10029-1 - Uso da Reserva Técnica Institucional - 2015
• Beneficiário: Taize Machado Augusto
• Modalidade de apoio: Auxílio à Pesquisa - Reserva Técnica para Infraestrutura Institucional de Pesquisa
• Processo FAPESP: 18/17495-6 - Estudo in vivo dos efeitos do extrato seco fitoterápico Polypodium leucotomos no câncer oral
• Beneficiário: Guilherme Cuoghi Bellato
• Modalidade de apoio: Bolsas no Brasil - Iniciação Científica
• Processo FAPESP: 16/21347-7 - Efeito do extrato do fitoterápico Polypodium Leucotomos (PL) em linhagem celular de câncer de pele
• Beneficiário: Mariana Ayaka Yamashita
• Modalidade de apoio: Bolsas no Brasil - Iniciação Científica